Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert B Jenkins

Showing results (211-220 of 269) with videos related to

Pageof 27
Sort By:
Neuro-Oncology|April 12, 2014
Germline rearrangements in families with strong family history of glioma and malignant melanoma, colon, and breast cancerUlrika Andersson, Carl Wibom, Kristina Cederquist, et al.
The New England Journal of Medicine|October 21, 2005
Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancerEdward H Romond, Edith A Perez, John Bryant, et al.
Nature Genetics|October 1, 2013
The long noncoding RNA SChLAP1 promotes aggressive prostate cancer and antagonizes the SWI/SNF complexJohn R Prensner, Matthew K Iyer, Anirban Sahu, et al.
The Journal of Molecular Diagnostics : JMD|February 2, 2025
Clinical Validation of the TruSight Oncology 500 Assay for the Detection and Reporting of Pan-Cancer BiomarkersHussam Al-Kateb, Shannon M Knight, Gopinath Sivasankaran, et al.
Neuro-Oncology|August 10, 2016
Radiogenomics to characterize regional genetic heterogeneity in glioblastomaLeland S Hu, Shuluo Ning, Jennifer M Eschbacher, et al.
Nature Genetics|July 7, 2009
Variants in the CDKN2B and RTEL1 regions are associated with high-grade glioma susceptibilityMargaret Wrensch, Robert B Jenkins, Jeffrey S Chang, et al.
Neuro-Oncology|June 5, 2013
Genetic variants in telomerase-related genes are associated with an older age at diagnosis in glioma patients: evidence for distinct pathways of gliomagenesisKyle M Walsh, Terri Rice, Paul A Decker, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 11, 2012
A variable age of onset segregation model for linkage analysis, with correction for ascertainment, applied to gliomaXiangqing Sun, Jaime Vengoechea, Robert Elston, et al.
Neuro-Oncology|January 10, 2019
Using germline variants to estimate glioma and subtype risksJeanette E Eckel-Passow, Paul A Decker, Matt L Kosel, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 25, 2016
Approaching a Scientific Consensus on the Association between Allergies and Glioma Risk: A Report from the Glioma International Case-Control StudyE Susan Amirian, Renke Zhou, Margaret R Wrensch, et al.
Pageof 27

Showing results (211-220 of 269) with videos related to

Sort By:
Pageof 27
Neuro-Oncology|April 12, 2014
Germline rearrangements in families with strong family history of glioma and malignant melanoma, colon, and breast cancerUlrika Andersson, Carl Wibom, Kristina Cederquist, et al.
The New England Journal of Medicine|October 21, 2005
Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancerEdward H Romond, Edith A Perez, John Bryant, et al.
Nature Genetics|October 1, 2013
The long noncoding RNA SChLAP1 promotes aggressive prostate cancer and antagonizes the SWI/SNF complexJohn R Prensner, Matthew K Iyer, Anirban Sahu, et al.
The Journal of Molecular Diagnostics : JMD|February 2, 2025
Clinical Validation of the TruSight Oncology 500 Assay for the Detection and Reporting of Pan-Cancer BiomarkersHussam Al-Kateb, Shannon M Knight, Gopinath Sivasankaran, et al.
Neuro-Oncology|August 10, 2016
Radiogenomics to characterize regional genetic heterogeneity in glioblastomaLeland S Hu, Shuluo Ning, Jennifer M Eschbacher, et al.
Nature Genetics|July 7, 2009
Variants in the CDKN2B and RTEL1 regions are associated with high-grade glioma susceptibilityMargaret Wrensch, Robert B Jenkins, Jeffrey S Chang, et al.
Neuro-Oncology|June 5, 2013
Genetic variants in telomerase-related genes are associated with an older age at diagnosis in glioma patients: evidence for distinct pathways of gliomagenesisKyle M Walsh, Terri Rice, Paul A Decker, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 11, 2012
A variable age of onset segregation model for linkage analysis, with correction for ascertainment, applied to gliomaXiangqing Sun, Jaime Vengoechea, Robert Elston, et al.
Neuro-Oncology|January 10, 2019
Using germline variants to estimate glioma and subtype risksJeanette E Eckel-Passow, Paul A Decker, Matt L Kosel, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 25, 2016
Approaching a Scientific Consensus on the Association between Allergies and Glioma Risk: A Report from the Glioma International Case-Control StudyE Susan Amirian, Renke Zhou, Margaret R Wrensch, et al.
Pageof 27